Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{198698,
        author = {Dr Ramandeep Dugal and Dr Prashant Nakade and Dr Nilima Bukte and Momin Fatima and Mutwalli Farheen and Tahura Nadaf},
        title = {Dental Implant Considerations in Patients with Sarcoidosis: A Review},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {11},
        pages = {11741-11744},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=198698},
        abstract = {Sarcoidosis is a chronic multisystem granulomatous disease characterized by the formation of non-caseating granulomas in affected tissues. Although the lungs and lymphatic system are most commonly involved, the disease may affect virtually any organ, including structures within the oral and maxillofacial region. Oral manifestations are relatively rare but may involve the salivary glands, oral mucosa, and jaw bones, thereby influencing dental treatment planning. Dental implants represent a predictable and widely accepted treatment modality for the rehabilitation of partially or completely edentulous patients; however, systemic diseases affecting immune regulation and bone metabolism may influence implant success. In patients with sarcoidosis, chronic granulomatous inflammation, altered calcium metabolism, and the use of long-term corticosteroid therapy may potentially compromise bone healing and osseointegration. The purpose of this review is to discuss the pathophysiology of sarcoidosis, its oral manifestations, and the clinical considerations relevant to implant therapy in affected individuals.},
        keywords = {},
        month = {April},
        }